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To elucidate the local tissue cytokine response of dogs infected with Leishmania chagasi,
cytokine mRNA levels were measured in bone marrow aspirates from 27 naturally infected
dogs from Brazil and were compared with those from 5 uninfected control animals. Interferon-
g mRNA accumulation was enhanced in infected dogs and was positively correlated with
humoral (IgG1) but not with lymphoproliferative responses to Leishmania antigen in infected
dogs. Increased accumulation of mRNA for interleukin (IL)–4, IL-10, and IL-18 was not
observed in infected dogs, and mRNA for these cytokines did not correlate with antibody or
proliferative responses. However, infected dogs with detectable IL-4 mRNA had significantly
more severe symptoms. IL-13 mRNA was not detectable in either control or infected dogs.
These data suggest that clinical symptoms are not due to a deficiency in interferon-g pro-
duction. However, in contrast to its role in human visceral leishmaniasis, IL-10 may not play
a key immunosuppressive role in dogs.
Leishmania infantum and L. chagasi, which cause human and
canine visceral leishmaniasis (VL) in Europe and Latin Amer-
ica, are maintained largely in domestic dog populations. Canine
VL is a major veterinary and public health problem in areas
where the disease is endemic and has been suggested as a good
model for investigating the pathogenesis of human VL. Both
diseases are associated with depressed peripheral antigen–
specific interferon (IFN)–g production [1, 2], which can be re-
versed by neutralization of interleukin (IL)–10 in human pe-
ripheral blood mononuclear cell (PBMC) cultures [3, 4]. It is
surprising that IFN-g mRNA accumulation is observed in the
tissues of patients with active VL and that it remains relatively
unaltered after curative chemotherapy. In contrast, tissue IL-
10 mRNA accumulation decreases after successful chemother-
apy, which suggests that IL-10–mediated inhibition of IFN-
g–induced macrophage activation, rather than regulation of
IFN-g production per se, is central to the pathogenesis of hu-
man VL [3–5]. Th2 cytokines, including IL-4 and IL-13, are
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variably expressed in human VL, and there is no direct evidence
that they inhibit protective responses [3, 6]. Despite accumu-
lating data on human VL, the paucity of comparable data on
canine VL has precluded further comparisons.
To address this issue, we measured cytokine (IFN-g and IL-
4, IL-10, IL-13, and IL-18) mRNA levels in bone marrow biopsy
specimens from dogs with naturally acquired VL in Brazil. These
dogs were part of a larger cohort study of L. chagasi infection
[7, 8]. Here, we provide a comparison of tissue cytokine mRNA
accumulation in infected and uninfected dogs and describe the
relationships among cytokine mRNA accumulation, anti-Leish-
mania immune responses, and clinical status.
Materials and Methods
Study animals. Details of the study site (Salvaterra, Marajo´
Island, Para´, Brazil) are described elsewhere [7]. A cohort study
was done using 126 initially uninfected dogs in a VL-endemic area;
the dogs were sampled approximately every 2 months for 823
days (April 1993 to July 1995). During the study, a proportion of
dogs became infected as a result of natural disease transmission;
dogs were not experimentally infected. Cytokine mRNA was as-
sessed in 29 of these study dogs (27 infected and 2 uninfected) in
May or July 1995, after they were exposed to infection for 208–798
days, as well as in 3 uninfected, unexposed dogs from the city of
Bele´m. Of the 29 exposed dogs, 27 showed evidence of infection.
Among 21 of these dogs, infection was confirmed by parasitologic
or polymerase chain reaction (PCR) analysis or xenodiagnosis; the
other 6 dogs mounted both positive cellular and humoral responses
to Leishmania antigen. For the purpose of this study, we considered
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all 27 dogs to be infected; comparable results were obtained when
analysis was restricted to dogs with confirmed infection. The time
of infection was estimated as the earliest time infection was detected
by parasitologic, PCR, or serologic analysis [8].
Clinical examination. Dogs were scored for 6 symptoms of
canine VL: alopecia, dermatitis, chancres, conjunctivitis, onycho-
gryphosis (excessive nail growth), and lymphadenopathy (enlarged
popliteal lymph nodes). Each symptom was scored on a semi-
quantitative scale from 0 (absent) to 3 (severe); scores were added
to give an overall clinical score. Dogs were classified as healthy
(score, 0–2), oligosymptomatic (score, 3–6), or polysymptomatic
(score, 7–18). Severely incapacitated dogs were killed with sodium
pentobarbitone.
Sampling. Dogs were anesthetized with a mixture of medeto-
midine hydrochloride and ketamine. A 20-mL blood sample was
obtained from the jugular vein. Bone marrow was aspirated from
the iliac crest with a –mm Klima needle (Veterinary Instru-16 25
ments) into a 20–mL syringe containing EDTA, and an aliquot was
preserved immediately in liquid nitrogen until used for RNA
extraction.
Reverse transcription–PCR analysis. Total RNA was extracted,
using Tri reagent (Sigma), and then was treated with DNase I (Life
Technologies) and was reverse-transcribed (random primers, Super-
script II; Life Technologies), according to manufacturer’s instruc-
tions. Diluted cDNA (1.5 mL) was amplified with PCR Master Mix
(ABgene) and 10 pmol of each primer in a total volume of 25 mL.
Reaction conditions were 94C (1 min), 50C–55C (1.5 min), and
72C (2 min); annealing temperatures were 55C for the housekeeping
gene b-actin and IL-18 and 50C for other cytokines. Negative con-
trols (water) were run in each set of PCRs. Six microliters of each
PCR product was transferred to nylon membrane, was probed with
a digoxygenin-labeled internal oligonucleotide (Boehringer Mann-
heim), according to the manufacturer’s instructions, and was assessed
by probe binding in a micro-beta counter (Wallac).
Oligonucleotide primers and probes. Primers and probes were
adapted from published sources using canine sequences from
GenBank [9–11]. Forward and reverse primers, internal probes, and
the number of cycles, respectively, were as follows:b-actin, CTTCTA-
CAACGAGCTGCGCG, TCATGAGGTAGTCGGTCAGG, and
CACACGGTGCCCATCTATGA (29 cycles); IFN-g, TTTTGAA-
GAAATGGAGAGAGG, AAATTCAAATAGTGCTGGCAGG,
and AAAGAGACAATTTGGCTCTG (40 cycles); IL-4, TATTA-
ATGGGTCTCACCTCCCA, TTGATTTCATTCATAGAACAG,
and AAGTTATGTCCGTGGACAAAG (45 cycles); IL-10, TAC-
CTGGGTTGCCAAGCCCT, TTCACAGAGAAGCTCAGTAA-
AT, and CACAGGGAAGAAATCGGTGA (40 cycles); IL-13,
CTGTGGTCATTGCTCTCACCT, TCACCAACTGGATCACT-
TCAA, and CTCAAGGAGCTCATTGAGGAG (45 cycles); and
IL-18, ATGGCTGCTAACCTAATAGAAGAC, CTAGCTCTT-
GTTTTGAACAGTGAAC, and TACTTTGGCAAGCTTGAA-
CC (32 cycles).
Quantification of PCR analysis. Samples were amplified, blot-
ted, and probed in duplicate in a single 96-well plate for each
cytokine. On each plate, a dilution series of positive control cDNA
was included. The positive control cDNA consisted of pooled sam-
ple cDNA, except for IL-4 and IL-13, in which cases, cDNA was
prepared from a 12-h culture of concanavalin A–stimulated PBMC
from an uninfected dog. The dilution of each sample cDNA was
adjusted to approximately equalize b-actin cDNA levels. For each
cytokine, undiluted positive control cDNA was assigned an arbi-
trary number of units of mRNA (1000 U), a standard curve of
counts per minute versus log (mRNA units) was constructed, and
the number of units of mRNA in each sample was estimated. All
samples were on the linear range of the standard curve for b-actin,
IL-10, and IL-18; samples below the linear range for IFN-g were
scored as zero. For IL-4 and IL-13, all samples were below the
linear range, and samples were scored as detectable (i.e., counts
per minute greater than background) or not detectable.
Immunologic assays. Lymphoproliferative responses to soni-
cated L. chagasi antigen were assessed, as described elsewhere [8],
and were expressed as a stimulation index (SI [i.e., the ratio of the
geometric mean counts per minute of stimulated wells to unstimu-
lated wells]). IgG and IgG subclass responses to L. chagasi antigen
were measured by ELISA, as described elsewhere [7], using a panel
of monoclonal antibodies [12]. Results were expressed as arbitrary
units calculated from a reference serum titrated on each plate. Among
the 27 infected dogs, lymphoproliferative responses were measured
in 26, IgG subclass responses in 26, and both in 25.
Statistical analysis. Levels of IL-10, IL-18, b-actin mRNA,
and antibodies and cellular responses were approximately log-nor-
mally distributed and were analyzed after log-transformation. IL-
4 mRNA was analyzed as a binary variable by logistic regression.
IFN-g mRNA levels were not normally distributed after transfor-
mation and were analyzed by nonparametric statistics. To control
for the relative amount of mRNA in each sample, the b-actin
mRNA level was included as a covariate in parametric analyses,
and IFN-g mRNA levels were divided by the b-actin mRNA level
before analysis. The clinical score was analyzed as a Poisson vari-
able, with overdispersion accounted for by adjusting the scale pa-
rameter to equal the Pearson’s x2 divided by the residual degrees
of freedom. Stata 6.0 (Stata) was used for analyses.
Results
Cytokine mRNA levels in infected and uninfected dogs. All
5 uninfected dogs had detectable IL-10 and IL-18 mRNA in
their bone marrow. However, IFN-g and IL-13 mRNAs were
undetectable, and IL-4 was detected in only 1 of 5 dogs (table
1). In infected dogs, there was a significant increase in bone
marrow IFN-g mRNA ( , Mann-Whitney U test).Pp .015
However, there was no increase in the accumulation of mRNA
for IL-10 ( ) or IL-18 ( ) or in the proportion ofPp .62 Pp .52
dogs with detectable IL-4 ( ). No infected dog producedPp .35
detectable levels of IL-13 mRNA. Cytokine mRNA accumu-
lation in infected dogs did not vary significantly with estimated
time since infection. Of the 27 infected dogs, 25 were seroposi-
tive at the time of sampling, and 2 had serorecovered. Of 26
infected dogs, 23 had a positive cellular response ( ).SI 1 3
Relationships between clinical status and immune responses in
infected dogs. There was a significant positive relationship
between clinical score and detectable IL-4 mRNA in infected
dogs ( ; ). There was a similar relationship2x p 3.98 Pp .046
between clinical score and anti-Leishmania IgG levels ( 2x p
; ), but there was no relationship with cellular10.71 Pp .0011
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Table 1. Cytokine mRNA levels (arbitrary units) in uninfected and Leishmania chagasi–
infected dogs.
Variable
Uninfected
(n p 5)
Asymptomatic
(n p 14)
Oligosymptomatic
(n p 7)
Polysymptomatic
(n p 6)
Interleukin-18 39 (14–104) 43 (30–62) 34 (15–74) 50 (27–92)
Interleukin-10 28 (11–72) 50 (28–89) 37 (16–86) 63 (24–170)
Interferon-g 0 (0–0) 5 (0–13) 8 (0–33) 11 (0–21)
Interleukin-4 0.20 (0.01–0.72) 0.29 (0.08–0.58) 0.43 (0.10–0.82) 0.67 (0.22–0.96)
b-Actin 30 (23–40) 56 (41–77) 35 (22–57) 50 (31–80)
Days after infection 0 397 (289–505) 382 (208–557) 459 (363–554)
IgG (103) 1.5 (0.5–4.5) 11 (5–25) 141 (66–302) 185 (65–528)
Stimulation index 1.9 (0.59–6.3) 9.5 (5.5–17) 12 (4.2–32) 5.1 (1.7–15)
NOTE. Data are geometric mean (95% confidence interval [CI]), except for the following: interferon-g,
which is shown as median (interquartile range); interleukin-4, which is shown as proportion of dogs producing
detectable interleukin-4 (95% CI); and days after infection, which are shown as arithmetic mean (95% CI).
Infected dogs were grouped according to their clinical score.
Table 2. Multiple regression analysis of the re-
lationship between clinical score and immune re-
sponses in Leishmania chagasi–infected dogs.
Variable Slope (SE) x2 P
Interleukin-18 1.229 (0.557) 4.87 .027
Interleukin-10 0.256 (0.274) 0.87 .351
Interferon-g 0.033 (0.021) 2.57 .109
Interleukin-4 1.646 (0.524) 9.86 .0017
b-Actin 0.596 (0.610) 0.96 .328
IgG 1.046 (0.275) 14.46 .0001
Stimulation index 1.981 (0.609) 10.57 .0011
response or other cytokines. When the relationship between
clinical score and immune responses was tested by multiple
regression, there was a highly significant positive relationship
between clinical score and both IgG and IL-4 mRNA, and there
was a negative relationship with both cellular responsiveness
and IL-18 mRNA (table 2).
Relationships between immune responses in infected dogs.
There was a significant positive correlation between IFN-g
mRNA accumulation and anti-Leishmania IgG in infected dogs
(Kendall’s ; ; ). This correlation wastp .400 np 27 Pp .005
significant for IgG1 ( ; ; ); however, ittp .323 np 26 Pp .027
was weaker and not significant for IgG2 ( ; ;tp .222 np 26
), IgG3 ( ; ; ) and IgG4 (Pp .14 tp .164 np 26 Pp .27 tp
; ; ). There were no other significant corre-.127 np 26 Pp .40
lations between cytokine mRNA levels and either antibody or
cellular responses. IL-18 and IL-10 mRNA levels were signifi-
cantly positively correlated in infected dogs (partial ;rp .593
). There were no other significant correlations amongPp .0014
cytokine mRNA levels.
Discussion
Tissue cytokine responses have been measured in human VL
and in hamster and murine models [3–5, 13, 14], yet, to our
knowledge, a similar approach has not been applied previously
to canine VL. Here, in a study of naturally infected dogs, the
primary feature identified as distinguishing canine VL from that
in man [3–5], mouse [13], and hamster [14] is the absence of
high-level accumulation of IL-10 mRNA in infected tissues.
The basal levels of IL-10 mRNA in normal bone marrow pre-
sumably reflect its regulatory role in hematopoiesis [15], al-
though concurrent infections cannot be ruled out. However,
even in dogs with severe disease, IL-10 mRNA accumulation
was comparable with that of uninfected control dogs. Fur-
thermore, there was no relationship between IL-10 and any of
the immune parameters measured. In contrast, human VL is
associated with increased tissue accumulation of IL-10 mRNA
and increased levels of serum IL-10 [3–6]. Indeed, a recent re-
port suggests that serum IL-10 is independently regulated com-
pared with other Th2 (IL-4 and IL-13) or Th1 (IFN-g) cyto-
kines and that IL-10 in the absence of these other cytokines is
associated with relapsing disease [6].
In contrast to the IL-10 results, our data show that mRNA
accumulation for IFN-g was, as expected, increased as a con-
sequence of infection. Indeed, dogs with asymptomatic and
polysymptomatic infections accumulated similar levels of IFN-
g mRNA. IFN-g production was strongly associated with anti-
body production, which suggests a general up-regulation of
anti-Leishmania immune responses in heavily infected hosts.
These data support the notion that, as in humans, mice, and
hamsters, levels of tissue IFN-g in dogs may not be the primary
indicator of disease status or eventual cure [3–6, 13, 14], but,
rather, that the inhibition of macrophage activation may play
a key role [16]. We found no evidence of a role for IL-10 in
this process, although it is possible that changes in IL-10 mes-
sage during infection may have been masked by any generalized
up-regulation of bone marrow mRNA synthesis. Further stud-
ies including other inhibitory cytokines, such as transforming
growth factor–b, are now required.
The role of IL-4 in VL remains controversial. Serum IL-4 has
been detected readily in some clinical studies but has not been
detected in others (see discussion in [6]). Although IL-4 has been
detected in murine VL, studies in IL-4/ mice surprisingly in-
dicate an essential role for this cytokine in both natural resistance
and successful chemotherapy [17]. Here, we found only a very
low accumulation of IL-4 mRNA in some, but not all, infected
dogs. However, there was a significant positive relationship be-
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tween IL-4 detection and disease severity, which suggests that
IL-4 production is associated with pathology.
IL-18, which may play an important role in the priming for
IFN-g production by T cells, has not previously been evaluated
in VL. Here, we detected IL-18 mRNA accumulation in both
control and infected dogs but did not identify any association
with infection per se. However, there was some evidence for a
protective role of IL-18 in infected dogs: there was a negative
relationship between IL-18 and clinical score, although this was
evident only when controlling for other immune responses.
There also was a positive correlation between IL-18 and IL-
10, which may reflect coordinate regulation of these macro-
phage-derived cytokines.
In summary, this study indicates that some, but not all, of
the features of cytokine regulation are shared between the vari-
ous forms of VL in different hosts. This finding cautions against
wholesale extrapolation of immune mechanisms between these
different diseases.
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